B
Berardino Tardio
Researcher at Casa Sollievo della Sofferenza
Publications - 6
Citations - 1521
Berardino Tardio is an academic researcher from Casa Sollievo della Sofferenza. The author has contributed to research in topics: Survival rate & Radiation therapy. The author has an hindex of 5, co-authored 6 publications receiving 1414 citations.
Papers
More filters
Journal ArticleDOI
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
Giuseppe Manghisi,Silvana Elba,Ascanio Mossa,Antonio Giorgio,V Aloisio,A. Perrotta,Berardino Tardio,Carlo Del Naja,Eugenio Caturelli,Maria Calandra,L. Castellano,Ilario de Sio,Gaetano Capuano,Domenico Pomponi,Fabiana Castiglione,Pasqualina Cocchia,Fabio Farinati,M. Rinaldi,Luigi Elio Adinolfi,Enrico Ragone,Martina Felder,Laura Zancanella,Giuseppe Pasquale,Maria Stanzione,Giampiero Marone,Valentina D’Angelo,Giovanni Battista Gaeta,Giancarlo Giolitto,Bruno Lamborgese,Luigi Manzione,Michele Russo,Raffaele Colurcio,Enzo Veltri,Francesco Izzo,Gabriele Budillon,Nicola Caporaso,Camillo Del Vecchio Blanco,B. Galanti,Giuseppe Giusti,Gabriele Mazzacca,Silvio Monfardini,Felice Piccinino,Giuseppe Ruggiero,Ciro Gallo,Francesco Perrone,Sabino De Placido,Giuliana Canzanella,Bruno Daniele,Sandro Pignata +48 more
TL;DR: The aims of this study were to verify the value of known prognostic factors and to devise a prognostic index more sensitive than the commonly used Okuda stage, and to produce a new prognostic system that accounts for both liver function and tumor characteristics.
Journal ArticleDOI
Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia.
Giovanni Zaninotto,Vito Annese,Mario Costantini,Alberto del Genio,Michela Costantino,Magdalena Epifani,Giovanni Gatto,Vittorio D'onofrio,Luigi Benini,Sandro Contini,Daniela Molena,Giorgio Battaglia,Berardino Tardio,Angelo Andriulli,Ermanno Ancona +14 more
TL;DR: Laparoscopic myotomy is as safe as BoTx treatment and is a 1-shot treatment that cures achalasia in most patients and BoTx should be reserved for patients who are unfit for surgery or as a bridge to more effective therapies, such as surgery or endoscopic dilation.
Journal ArticleDOI
Fatal ulcerative panenteritis following colectomy in a patient with ulcerative colitis.
Vito Annese,Nazario Caruso,Michele Bisceglia,Giovanni Lombardi,R. Clemente,Giovanni Modola,Berardino Tardio,Maria Rosaria Villani,Angelo Andriulli +8 more
TL;DR: A 37-year-old man, previously submitted to colectomy for ulcerative pancolitis unresponsive to medical therapy, presented with nausea, vomiting, epigastric pain, and bloody diarrhea as mentioned in this paper.
Journal ArticleDOI
Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinoma.
Roberto Labianca,Roldano Fossati,Alberto Zaniboni,Valter Torri,Silvia Marsoni,Donato Nitti,Lamberto Boffi,Marco Scatizzi,Berardino Tardio,Nicola Mastrodonato,Stefano Banducci,Giampiero Consani,Gianfranco Pancera +12 more
TL;DR: Overall and event-free survival rates were similar in all three arms, and the combined regimen was no better than either single regimen alone.
Journal ArticleDOI
Intermediate neoadjuvant radiotherapy for T3 low/middle rectal cancer: postoperative outcomes of a non-controlled clinical trial
Giovanni Bisceglia,Nicola Mastrodonato,Berardino Tardio,Gianluigi Mazzoccoli,Pietro Corsa,Michele Troiano,Salvatore Parisi +6 more
TL;DR: Preoperative radiotherapy with intermediate dose/duration and interval between radiotherapy and surgery achieves high local control in patients with cT3NxM0 rectal cancer, and high DR rate seems to be the major limitation to improved survival.